Dealmaking is a key driver of innovation and growth for life sciences companies. Regulation, complexity, scientific discovery and uncertainty are hallmarks of the sector, but can lead to higher-than-average attrition rates for deals.
This report, based on interviews with life sciences dealmaking veterans, looks at key risk factors for buyers and sellers in life sciences deals - and how to avoid them to increase the probability of deal success.
Please complete the form to download the report.
%20front%20cover%20reduced.jpg?width=222&height=314&name=9892%20-%20Final%20-%20Report%20Styling%20(RGB)%20front%20cover%20reduced.jpg)
Apr 4, 2023, 1:51:57 PM
